Integra LifeSciences

Historical price data

Integra LifeSciences is a publicly traded, revenue-generating medical technology company with a $1.6B revenue base, specializing in high-margin, clinically differentiated products for neurosurgery and tissue reconstruction. The company's strategy combines organic innovation with strategic acquisitions to build and defend leadership positions in niche surgical markets, exemplified by its flagship collagen-based regenerative templates and the Codman neurosurgery portfolio. Recent leadership appointments and a focus on operational remediation aim to strengthen its innovation pipeline and quality systems for long-term growth, despite near-term financial and execution headwinds.

Integra's technology is built on two interconnected pillars: proprietary regenerative biomaterial platforms (collagen-based and synthetic matrices for tissue repair) and integrated surgical systems (including ultrasonic aspiration, CSF management, and specialized instrumentation) for neurosurgery and other specialties.